SCHEDULE 13G: Healthcare of Ontario Pension Plan Discloses Significant 8.6% Stake in Oaktree Acquisition Corp. III Life Sciences
Beneficial Ownership Disclosure
The Healthcare of Ontario Pension Plan Trust Fund (HOOPP) has disclosed an 8.6% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences, holding 1.7 million Class A ordinary shares.
Summary
- The Healthcare of Ontario Pension Plan Trust Fund (HOOPP) has filed a Schedule 13G, reporting beneficial ownership of Class A ordinary shares of Oaktree Acquisition Corp. III Life Sciences.
- HOOPP holds 1,700,000 Class A ordinary shares, representing 8.6% of the issuer's outstanding Class A shares.
- The percentage ownership is based on 19,783,010 Class A shares issued and outstanding as of October 30, 2024, as reported by the Issuer.
- HOOPP, a pension plan formed as a trust under the laws of Ontario, Canada, holds sole voting and sole dispositive power over all 1,700,000 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive. While a Schedule 13G is a routine disclosure, the presence of a significant stake by a large, reputable institutional investor like HOOPP can be viewed favorably by the market, indicating confidence or strategic interest in the issuer.
Positives
- The disclosure of a significant stake by a large, reputable institutional investor like the Healthcare of Ontario Pension Plan Trust Fund can signal confidence in Oaktree Acquisition Corp. III Life Sciences.
- Institutional ownership can enhance the company's credibility and potentially attract further investment.
Risks
- This Schedule 13G filing does not detail any specific business or operational risks pertaining to Oaktree Acquisition Corp. III Life Sciences.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding the future outlook of Oaktree Acquisition Corp. III Life Sciences or the investment strategy of HOOPP beyond the certification of holding shares in the ordinary course of business.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11." (Abas Kanu, VP, HOOPP Compliance Officer)
- "By signing below I certify that, to the best of my knowledge and belief, the regulatory scheme applicable to a pension plan formed as a trust under the laws of Ontario, Canada and registered with the Financial Services Regulatory Authority of Ontario is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s)." (Abas Kanu, VP, HOOPP Compliance Officer)
Industry Context
This filing highlights continued institutional interest in Special Purpose Acquisition Companies (SPACs) within the life sciences sector. Large pension funds like HOOPP often allocate capital to a diversified portfolio, including investments in blank check companies that aim to merge with private operating businesses, particularly in high-growth sectors like life sciences.
Comparison to Industry Standards
- As a Schedule 13G filing, this document primarily serves as a disclosure of beneficial ownership by an institutional investor and does not provide financial results or operational performance metrics for Oaktree Acquisition Corp. III Life Sciences that would allow for a direct comparison to industry standards or specific comparable companies' project results.
- The holding of an 8.6% stake by a major pension fund is a significant institutional investment, aligning with typical large-scale portfolio allocations seen among global pension plans.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake may positively influence investor perception and potentially the share price, signaling confidence from a major investor.
Key Dates
| Date | Description |
|---|---|
| 2024-10-30 | Date as of which the number of Class A Shares issued and outstanding (19,783,010) was calculated, based on the Issuer's Form 8-K filing. |
| 2024-12-31 | Date of event which required the filing of this statement. |
| 2025-02-14 | Date of filing and signature of the Schedule 13G statement. |
Keywords
Oaktree Acquisition Corp. III Life Sciences, Healthcare of Ontario Pension Plan Trust Fund, HOOPP, Schedule 13G, Beneficial Ownership, Class A ordinary shares, SPAC, Institutional Investor, Pension Fund, Life Sciences
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.